Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
David K. Wilson's research group focuses on the study of pediatric gliomas and sickle cell disease. His recent work includes investigations into targeted inhibition strategies for pediatric gliomas with MET and ALK alterations, examining objective responses and subsequent treatment resistance.
In parallel, Wilson's group is exploring the health implications of sickle cell disease in children. This includes research on the impact of parental adverse childhood experiences on healthcare utilization among children with sickle cell disease, as well as multimodal neuroimaging and neurocognitive assessments in adolescents with and without the condition. He also has publications related to rare pediatric oncological presentations, such as germinoma mimicking optic pathway glioma, and neonatal Langerhans cell histiocytosis.
Wilson's scholarly output is marked by a h-index of 35 and over 3,700 citations across 119 publications. He has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Murat Gökden, Kevin Bielamowicz, Eylem Öcal, and Sateesh Jayappa, with whom he shares multiple publications.
Metrics
- h-index: 35
- Publications: 118
- Citations: 3,702
Selected Publications
-
Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease (2025)
-
Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance (2025)
-
TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case (2025)
-
Isolated eyelid neonatal Langerhans cell histiocytosis (2024)
Collaboration Network
Top Collaborators
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- It is not just a headache: a case report of a patient with CNS HLH due to griscelli type II
- A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Nature of the Nickel-Halogen Bond in NiX<sup>+</sup> Compounds (X = F, Cl, Br, I): A Multireference Configuration Interaction and Ab Initio Valence Bond Study
- Preparation, Spectroscopic Characterization, and Reactivity of High-Valent Non-Oxo Co(IV) and Formally Co(V) Complexes
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Multimodal neuroimaging and neurocognitive assessment in adolescents with and without sickle cell disease
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance
- TARGETED INHIBITION IN PEDIATRIC MET and ALK ALTERED PEDIATRIC HIGH GRADE GLIOMAS: OBJECTIVE RESPONSES FOLLOWED BY TREATMENT RESISTANCE
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
- Isolated eyelid neonatal Langerhans cell histiocytosis
Similar Researchers
Based on overlapping research topics